APH-1105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APH-1105, covering 2021-07-27 to 2021-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]